Kelfred Holdings (HKSE:01134) EBIT : HK$3.9 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Kelfred Holdings EBIT?

Kelfred Holdings's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was HK$-3.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$3.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Kelfred Holdings's annualized ROC % for the quarter that ended in Dec. 2023 was -21.77%. Kelfred Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -4.90%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Kelfred Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1.91%.

Kelfred Holdings EBIT Historical Data

The historical data trend for Kelfred Holdings's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kelfred Holdings EBIT Chart

Kelfred Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

15.88

-11.35

-1.09

11.42

3.86

Kelfred Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial									0.84	13.12	-1.71	7.73	-3.88

Competitive Comparison of Kelfred Holdings's EBIT

For the Medical Instruments & Supplies subindustry, Kelfred Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kelfred Holdings's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kelfred Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kelfred Holdings's EV-to-EBIT falls into.

Kelfred Holdings EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$3.9 Mil.

Kelfred Holdings (HKSE:01134) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Kelfred Holdings's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-41.646 * ( 1 - 9.67% )	/	( (149.942	+	195.701)	/ 2 )
=	-37.6188318	/	172.8215
=	-21.77 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	254.152	-	52.716	-	( 51.494	-	max(0, 55.976	-	206.882	+	51.494	))
=	149.942

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	264.004	-	47.969	-	( 20.334	-	max(0, 68.143	-	212.668	+	20.334	))
=	195.701

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Kelfred Holdings's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-7.754	/	( ( (47.27 + max(93.383, 0))	+	(50.829 + max(125.03, 0)) )	/	2 )
=	-7.754	/	( ( 140.653	+	175.859 )	/	2 )
=	-7.754	/	158.256
=	-4.90 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(79.237	+	67.631	+	0.16800000000001)	-	(52.716	+	0	+	0.937)
=	93.383

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(109.067	+	74.764	+	6.595)	-	(47.969	+	0	+	17.427)
=	125.03

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Kelfred Holdings's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	3.856	/	202.385
	=	1.91 %

Kelfred Holdings EBIT Related Terms

Thank you for viewing the detailed overview of Kelfred Holdings's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Kelfred Holdings (HKSE:01134) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kelfred Holdings Ltd (HKSE:01134) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 On Ping Street, Workshops 1605-1606, 16th Floor, Block B, New Trade Plaza, Sha Tin, New Territories, Hong Kong, HKG

Website

https://www.kelfred.com.hk

Kelfred Holdings Ltd is an eyewear manufacturer in the PRC and Hong Kong. It manufactures and sells a wide range of spectacle frames and sunglasses mainly through original design manufacturing and original equipment manufacturing business models. It offers integrated and customized services which include product design and development, raw materials procurement, production, quality control, packaging, and delivery. In addition to the traditional OEM and ODM business models, the group also offers its original brand manufacturing (OBM) products under the brand Miga. The group operates in Italy, United Kingdom, Netherlands, Hong Kong, France, Spain, Japan, Hungary, the United States, and others.

Executives

Conquer Holding Limited	2101 Beneficial owner
Chan Yin Wah	2201 Interest of corporation controlled by you
Kwok Kwan Fai	2201 Interest of corporation controlled by you
Kwok Kwan Yu	2201 Interest of corporation controlled by you
Kwok Mau Kwan	2202 Interest of your spouse
Li Man Yee Stella	2202 Interest of your spouse
Siu Fong Ting Tammy	2202 Interest of your spouse

Kelfred Holdings (HKSE:01134) Headlines

No Headlines